Loading...
NXY-059 for acute ischemic stroke: the promise of neuroprotection is finally realized
Fisher, Marc
Fisher, Marc
Citations
Altmetric:
Authors
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Journal Article
Publication Date
2006-09-02
Keywords
Benzenesulfonates
Biological Markers
Clinical Trials, Phase III as Topic
Double-Blind Method
Fibrinolytic Agents
Free Radical Scavengers
Hemorrhage
Humans
Neuroprotective Agents
Nitrogen Oxides
Randomized Controlled Trials as Topic
Sample Size
Severity of Illness Index
Stroke
Thrombolytic Therapy
Tissue Plasminogen Activator
Treatment Outcome
Life Sciences
Medicine and Health Sciences
Biological Markers
Clinical Trials, Phase III as Topic
Double-Blind Method
Fibrinolytic Agents
Free Radical Scavengers
Hemorrhage
Humans
Neuroprotective Agents
Nitrogen Oxides
Randomized Controlled Trials as Topic
Sample Size
Severity of Illness Index
Stroke
Thrombolytic Therapy
Tissue Plasminogen Activator
Treatment Outcome
Life Sciences
Medicine and Health Sciences
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
Source
Stroke. 2006 Oct;37(10):2651-2. Epub 2006 Aug 31. Link to article on publisher's site
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1161/01.STR.0000242800.29490.a1
Permanent Link to this Item
PubMed ID
16946143